Healthcare & Life Sciences
IsomAb
United Statesisomab.bio
IsomAb is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 1 tracked investor.
Activeseed
seed
Stage
1
Investors
About IsomAb
IsomAb is a company headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
IsomAb develops first-in-class antibody therapeutics that selectively restore collateral vessel growth in the heart to treat coronary heart disease, with a lead program targeting stable angina.
Explore IsomAb's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.